---
title: "DaVita Inc. (DVA.US) — 公司概況"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/DVA.US/overview.md"
symbol: "DVA.US"
name: "DaVita Inc."
parent: "https://longbridge.com/zh-HK/quote/DVA.US.md"
datetime: "2026-04-05T02:41:28.274Z"
locales:
  - [en](https://longbridge.com/en/quote/DVA.US/overview.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/DVA.US/overview.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/DVA.US/overview.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/DVA.US/overview.md) | [简体中文](https://longbridge.com/zh-CN/quote/DVA.US/overview.md)


# DaVita Inc. (DVA.US) — 公司概況

## 基本資訊

| 項目 | 詳情 |
|------|--------|
| 行業 | Health Care Services |
| 交易所 | US Market |
| 地址 | 2000 16th Street, Denver, Colorado, United States |
| 官網 | [www.davita.com](https://www.davita.com) |

## 公司簡介

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

## 核心管理層

| 名稱 | 職位 |
|------|-------|
| Javier J. Rodriguez | CEO & Executive Director |
| Pamela M. Arway | Independent Chair |
| Joel Ackerman | CFO & Treasurer |
| David P. Maughan | Chief Operating Officer of Kidney Care |
| Kathleen Alyce Waters | Chief Legal & Public Affairs Officer |
| James O. Hearty | Chief Compliance Officer |
| Barbara J. Desoer | Independent Director |
| Phyllis R. Yale | Independent Director |
| Gregory J. Moore | Independent Director |

## 主要股東

| 名稱 | 佔比 | 報告日期 |
|------|-------|-------------|
| Berkshire Hathaway Inc. | 45.08% | 2026-01-29 |
| The Vanguard Group, Inc. | 6.22% | 2025-12-31 |
| BlackRock, Inc. | 4.38% | 2025-12-31 |
| Invesco Capital Management LLC | 2.27% | 2025-12-31 |
| State Street Global Advisors, Inc. | 2.15% | 2025-12-31 |
| Arrowstreet Capital, Limited Partnership | 1.78% | 2025-12-31 |
| Millennium Management LLC | 1.76% | 2025-12-31 |
| Gates Capital Management, Inc. | 1.76% | 2025-12-31 |
| Dimensional Fund Advisors LP | 1.63% | 2025-12-31 |
| Geode Capital Management, LLC | 1.47% | 2025-12-31 |

## 業務構成

| 業務線 | 營收 | 佔比 |
|---------|---------|-------|
| U.S. Dialysis Patient Services and Other | 11793000000 | 85.99% |
| Other - Ancillary Services - International | 1346000000 | 9.81% |
| Other - Ancillary Services - U.S. Integrated Kidney Care (IKC) | 542000000 | 3.95% |
| Other-Ancillary Services - U.S. Other Ancillary | 34000000 | 0.25% |
| Elimination of intersegment revenues | -72000000 | % |

```vega-lite
{
  "$schema": "https://vega.github.io/schema/vega-lite/v5.json",
  "title": "DaVita Inc. Business Breakdown",
  "data": {
    "values": [
      {
        "segment": "U.S. Dialysis Patient Services and Other",
        "ratio": 85.99
      },
      {
        "segment": "Other - Ancillary Services - International",
        "ratio": 9.81
      },
      {
        "segment": "Other - Ancillary Services - U.S. Integrated Kidney Care (IKC)",
        "ratio": 3.95
      },
      {
        "segment": "Other-Ancillary Services - U.S. Other Ancillary",
        "ratio": 0.25
      },
      {
        "segment": "Elimination of intersegment revenues",
        "ratio": null
      }
    ]
  },
  "mark": "arc",
  "encoding": {
    "theta": {
      "field": "ratio",
      "type": "quantitative"
    },
    "color": {
      "field": "segment",
      "type": "nominal"
    }
  }
}
```


---

> **免責聲明: 本文僅供參考，不構成任何投資建議。**